Geisinger Health System CEO, Dr. David Feinberg reveals health system’s pioneering precision health efforts will be recommended to every patient.
Efficiently translating genomic research into the clinic is one of the most important steps in the development of the field. The clinic is where we will see things come to fruition.
Cryptographic system could enable ‘crowdsourced’ genomics, with volunteers contributing information to privacy-protected databases.
A new cell-based medicine is offering hope for children suffering from incurable nerve tissue cancer, posing a dilemma for investors.
For the first time, scientists have revealed the essential genes for the most deadly human malaria parasite, Plasmodium falciparum. They have created new genomic techniques to analyse every gene in the parasite and determine which ones are indispensable.
Now, Salk researchers have demonstrated in mice that haemophilia B can be treated for life with one single injection, containing disease-free liver cells that can produce their missing clotting factor.
Thermo Fisher Scientific has signed agreements with Takeda Pharmaceuticals and Daiichi Sanyo that will enable the Japanese firms to leverage Thermo Fisher’s FDA approved Oncomine Dx Target Test for their clinical trials and drug development programs.
There are many different techniques for DNA and RNA amplification. By far the most common method, however, is the Polymerase Chain Reaction (PCR). This simple guide will tell you everything you need to know about PCR.
Biotech startup Mammoth Biosciences launches a CRISPR powered search engine that ‘works like Google’ for disease detection.
23andMe has provided their customers with a new health portal that makes it possible to share how they manage 18 common health conditions, including depression, ADHD, migraine and asthma.
To fully benefit from the vast quantities of data from TCGA, tools for easy data visualisation and analysis must be developed for use of the non-computational scientist. Our panel of experts discuss TCGA data and the tools needed to make sense of it.
New data indicates that newly diagnosed lung cancer patients have a 50% increase in survival rate over 1 year when receiving Keytruda over traditional chemotherapy.